Gefitinib was shown to promote autophagy in lung cancer cell lines, as indicated by LC3II lysosomal localization, increased ATG5 and ATG7 expression at the mRNA or protein levels, and reduced phosphorylation of the PI3K/Akt/mTOR pathway [74,75]. This evidence concerns the gene AKT1 and lung carcinoma.